CDK2 and hepatocellular carcinoma: CDK2/cyclin E1 phosphorylated NF90 at serine 382 (Fig. 1), which was the key step driving NF90–mediated stabilization of cyclin E1 mRNA and promoted HCC cell proliferation in vitro (Fig. 2) and in vivo (Fig. 3).